WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
NYSE Amends Shareholder Approval Requirements
Alerts
April 13, 2021

On April 2, 2021, the Securities and Exchange Commission (SEC) approved the proposed rule change filed by the New York Stock Exchange (NYSE) to amend certain of the shareholder approval requirements in the NYSE Listed Company Manual. These amendments are intended to align the NYSE's shareholder approval requirements more closely with the requirements of the Nasdaq Stock Market and the NYSE American, and are similar in effect to the temporary relief that was provided to NYSE-listed companies in light of the COVID-19 pandemic. The temporary relief was discussed in our previous alert.

Section 312.03 of the NYSE Listed Company Manual requires NYSE-listed companies to obtain shareholder approval prior to the issuance of common stock, or securities convertible into or exercisable for common stock, in certain circumstances. The amendments modify the shareholder approval requirements relating to 1) certain related party equity issuances and 2) private placement transactions involving the issuance of 20 percent or more of the company's common stock or voting power outstanding before the issuance.

Related Party Issuances

Section 312.03(b) of the NYSE Listed Company Manual requires NYSE-listed companies to obtain shareholder approval for the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions, to 1) a "related party," 2) a subsidiary, affiliate, or other closely related person of a related party, or 3) any company or entity in which a related party has a substantial direct or indirect interest, if the number of shares to be issued exceeds either 1 percent of the number of shares of common stock or 1 percent of the voting power outstanding before the issuance. Related parties include directors, officers, or substantial security holders (i.e., 5 percent or more of the shares of common stock or voting power outstanding) of the company.

The amendments modify Section 312.03(b) as follows:

  • Class of persons for which approval is required. Shareholder approval will only be required for issuances to a related party, and will not be required for issuances to 1) a subsidiary, affiliate, or other closely related person of a related party, or 2) any company or entity in which a related party has a substantial direct or indirect interest.

    Notwithstanding the foregoing, shareholder approval will be required where securities are issued as consideration in a transaction or series of related transactions in which 1) any related party has a 5 percent or greater interest (or such persons collectively have a 10 percent or greater interest), directly or indirectly, in the company or assets to be acquired or in the consideration to be paid and 2) the present or potential issuance of common stock, or securities convertible into common stock, could result in an issuance that exceeds either 5 percent of the number of shares of common stock or of the voting power outstanding before the issuance. Thus, while the NYSE has eliminated the shareholder approval requirement for issuances to a subsidiary or affiliate of a related party, under this amended provision, shareholder approval may be required where a related party has an interest in the company or assets to be acquired.
  • Cash sales at minimum price. Shareholder approval will not be required for issuances to a related party if the transaction is a cash sale for a price that is at least the "minimum price." The minimum price is the price that is the lower of 1) the closing price immediately preceding the signing of the binding agreement or 2) the average closing price for the five trading days immediately preceding the signing of the binding agreement.1 This expands upon the exception to the shareholder approval requirement for cash sales, which, prior to these amendments, was limited to 1) related parties that were substantial security holders (and not directors or officers) and 2) cash sales relating to no more than 5 percent of the shares of common stock or voting power outstanding that meet the minimum price requirement.

    Shareholder approval will continue to be required for 1) any non-cash sales to related parties and 2) any cash sales to related parties at a price that is lower than the minimum price, in each case, in transactions where the number of shares to be issued exceeds either 1 percent of the company's common stock or voting power prior to the issuance.

In addition to the amendments to Section 312.03(b), the NYSE also amended Section 314.00 to require that transactions with related parties be reviewed in advance by the company's audit committee or another body of independent directors. Any such transaction will be prohibited if the audit committee or other body of independent directors determines that it would be inconsistent with the interests of the company and its shareholders.

Although the amendments to Section 312.03(b) provide some flexibility for companies seeking to raise capital in the private markets, 1) any sales to employees, directors, or service providers will continue to be subject to the equity compensation rules in Section 303A.08 of the NYSE Listed Company Manual, which require shareholder approval of equity compensations plans and material revisions thereto, and 2) shareholder approval will still be required if any of the other subsections of Section 312.03 require such approval, notwithstanding these amendments.

20 Percent or Greater Issuances

Section 312.03(c) of the NYSE Listed Company Manual requires NYSE-listed companies to obtain shareholder approval for the issuance of common stock, or of securities convertible into or exercisable for common stock, in any transaction or series of related transactions if the number of shares of common stock to be issued will equal or exceed 20 percent of the number of shares common stock or 20 percent of the voting power outstanding before the issuance, except for 1) any public offering for cash or 2) any "bona fide private financing" involving a cash sale of the company's securities that complies with the minimum price requirement.

A bona fide private financing is a sale in which either 1) a registered broker-dealer purchases the securities from the company with a view to the private sale of securities to one or more purchasers or 2) the company sells the securities to multiple purchasers, and no one such purchaser, or group of related purchasers, acquires, or has the right to acquire upon exercise or conversion of the securities, more than 5 percent of the shares of the company's common stock or voting power before the sale.

The amendments modify Section 312.03(c) as follows:

  • Bona fide private financing. The term "bona fide private financing" has been replaced with "other financing (that is not a public offering for cash)." This change has the effect of expanding this exception to the shareholder approval requirement by eliminating both 1) the requirement in the exception that there be multiple purchasers and 2) the 5 percent limit for any single purchaser, or group of related purchasers, in cash sales meeting the minimum price requirement.
  • Issuances in connection with acquisitions or stock. Shareholder approval will be required if the securities in such "other financing" are issued in connection with an acquisition of the stock or assets of another company if the issuance of the securities alone or when combined with any other present or potential issuance of common stock, or securities convertible into common stock in connection with such acquisition, is equal to or exceeds either 20 percent of the number of shares of common stock or the voting power outstanding before the issuance.

    Shareholder approval will continue to be required for 1) any non-cash sales and 2) any cash sales at a price that is lower than the minimum price, in each case, in transactions relating to 20 percent or more of the company's common stock or voting power outstanding before such issuance.

What to Do Now?

These amendments provide increased flexibility for NYSE-listed companies seeking to raise capital in private placement transactions, potentially resulting in broader and quicker access to private capital. As always, prior to undertaking private financings, NYSE-listed companies should review the shareholder approval requirements to confirm whether the transaction will require shareholder approval under any of the applicable provisions of the NYSE Listed Company Manual or state law.

For any questions relating to the NYSE's shareholder approval requirements, or any related matter, please contact any member of Wilson Sonsini's public company representation practice.


[1] See Section 312.04(i) of the NYSE Listed Company Manual.

Contributors

  • Jose F. Macias
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.